Axsome Therapeutics (AXSM)

Axsome Therapeutics (AXSM) – FDA

Apr 1, 2024 07:02 AM Axsome Therapeutics (AXSM) Initiates ENGAGE Phase 3 Trial of Solriamfetol
Mar 25, 2024 06:31 AM Axsome Therapeutics (AXSM) Reports AXS-12 Met Primary Endpoint in the SYMPHONY Phase 3 Trial
Oct 24, 2023 07:02 AM
Feb 22, 2023 07:01 AM
Feb 13, 2023 09:09 AM
Nov 28, 2022 06:38 AM
Oct 20, 2022 07:01 AM
Oct 3, 2022 06:30 AM
Sep 29, 2022 07:08 AM
Sep 8, 2022 07:01 AM
Aug 19, 2022 02:13 PM
Aug 19, 2022 08:03 AM
Aug 19, 2022 07:23 AM
Aug 19, 2022 06:46 AM
Jun 27, 2022 07:17 AM
Jun 2, 2022 07:05 AM
Jun 1, 2022 07:01 AM
May 31, 2022 07:05 AM
May 18, 2022 07:03 AM
May 2, 2022 07:01 AM
Apr 25, 2022 08:29 AM
Apr 19, 2022 07:09 AM
Feb 7, 2022 05:14 PM
Sep 14, 2021 07:02 AM
Sep 14, 2021 07:00 AM
Aug 23, 2021 12:58 PM
Aug 9, 2021 01:33 PM
Aug 9, 2021 07:05 AM
Jun 15, 2021 07:01 AM
Apr 26, 2021 06:02 AM
Dec 31, 2020 06:33 AM
Dec 31, 2020 06:01 AM
Dec 8, 2020 06:28 AM
Dec 2, 2020 06:16 AM
Dec 1, 2020 06:03 AM
Sep 24, 2020 06:02 AM
Sep 21, 2020 07:04 AM
Sep 14, 2020 06:03 AM
Sep 10, 2020 07:05 AM
Aug 31, 2020 07:05 AM
Aug 20, 2020 07:01 AM
Aug 10, 2020 07:12 AM
Aug 5, 2020 07:18 AM
Jul 13, 2020 07:02 AM
Jun 26, 2020 07:01 AM
May 29, 2020 07:05 AM
Apr 27, 2020 06:56 AM
Apr 27, 2020 06:05 AM
Apr 6, 2020 06:13 AM
Mar 30, 2020 06:01 AM